NLRP3 and amyotrophic lateral sclerosis: In addition, these results stressed the relevance of ROS and ATP generation, both potential therapeutic targets, for microglial NLRP3 inflammasome activation and neuronal pyroptosis, which was confirmed in SOD1G93A-induced ALS-model mice.